# Vericel Corporation – FDA Inspection, Aug 21, 2009

Source: https://www.keypedia.com/records/fda_inspections/vericel-corporation/0c3973b6-e56f-4070-b7f7-a4b5a1a4dd38
Source feed: FDA_Inspections

> FDA inspection 608350 of Vericel Corporation, August 21, 2009. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR parts 211 and 600. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 608350
- Company Name: Vericel Corporation
- Inspection Date: 2009-08-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 7

## Related Documents

- [FDA Inspection 1322008 - 2026-06-12](https://www.keypedia.com/records/fda_inspections/vericel-corporation/02e881c9-9b82-410c-b598-43e33c6e9d99)
- [FDA Inspection 1249999 - 2024-09-25](https://www.keypedia.com/records/fda_inspections/vericel-corporation/14fd491e-b3d9-4240-a85a-736a89e99616)
- [FDA Inspection 1210597 - 2023-07-21](https://www.keypedia.com/records/fda_inspections/vericel-corporation/b6697f78-5c18-4b52-b12d-acb5f892368c)
- FDA Inspection 1006746 - 2016-05-27
- FDA Inspection 870615 - 2014-03-19

Company: https://www.keypedia.com/companies/vericel-corporation/1955c523-5115-491b-a705-2c526deb9ff6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d